Epigenetic alterations and anti-epigenetic therapy in myelofibrosis.
Tefferi
Ayalew
A
Division of Hematology, Mayo Clinic, Rochester, MN, USA. tefferi.ayalew@mayo.edu
D000970:Antineoplastic Agents; D016503:Drug Delivery Systems; D044127:Epigenesis, Genetic; D006801:Humans; D055728:Primary Myelofibrosis / Q000235:genetics* / Q000628:therapy*
D000970:Antineoplastic Agents